Missing Links?: 1093 Citation Matrix | Graphs | Glossary HistCite Guide About |
Nodes: 10146,
Authors: 16970,
Journals: 1137,
Outer References: 208320,
Words: 13772
Collection span: 1949 - 2005
View: Overview. Sorted by journal name.
Page 21 of 102: 1 11 [ 21 22 23 24 25 26 27 28 29 30 ] 31 41 51 61 71 81 91 | 101
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
---|---|---|---|---|---|
2001 | 1 | 9 | 473 1962 CANADIAN JOURNAL OF MICROBIOLOGY 8 (6): 933-& COOK FD; QUADLING C PEROXIDE PRODUCTION BY RHIZOBIUM MELILOTI | 0 | 4 |
2002 | 1 | 19 | 618 1963 CANADIAN JOURNAL OF MICROBIOLOGY 9 (2): 179-& ALLEN WE; MCVEIGH I GROWTH OF PENICILLIN-RESISTANT AND PENICILLIN-SENSITIVE STRAINS OF STAPHYLOCOCCUS AUREUS | 0 | 0 |
2003 | 1 | 13 | 777 1964 CANADIAN JOURNAL OF MICROBIOLOGY 10 (2): 221-& SCHWINGHAMER EA ASSOCIATION BETWEEN ANTIBIOTIC RESISTANCE + INEFFECTIVENESS IN MUTANT STRAINS OF RHIZOBIUM SPP | 0 | 49 |
2004 | 3 | 26 | 778 1964 CANADIAN JOURNAL OF MICROBIOLOGY 10 (4): 595-& BOROWSKI J DEVELOPMENT OF PENICILLIN-SENSITIVE MUTANTS IN COURSE OF NATURAL + EXPERIMENTAL INFECTION WITH PENICILLINASE-PRODUCING STAPHYLOCOCCUS AUREUS STRAINS | 0 | 2 |
2005 | 6 | 20 | 973 1965 CANADIAN JOURNAL OF MICROBIOLOGY 11 (2): 185-& MCCALLA DR NITROFURAN DERIVATIVES AS RADIOMIMETIC AGENTS - CROSS-RESISTANCE STUDIES WITH ESCHERICHIA COLI | 5 | 32 |
2006 | 1 | 20 | 974 1965 CANADIAN JOURNAL OF MICROBIOLOGY 11 (2): 213-& BERK RS EFFECT OF ANTIBACTERIAL AGENTS ON AUTOPLAQUE PHENOMENON OF PSEUDOMONAS AERUGINOSA | 0 | 11 |
2007 | 3 | 12 | 975 1965 CANADIAN JOURNAL OF MICROBIOLOGY 11 (2): 393-& VIENS P; SONEA S; DEREPENT.J INHIBITION DE LACTION ANTIBACTERIENNE DE LA PENICILLINE CHEZ DES STAPHYLOCOQUES CULTIVES EN PRESENCE DORANGE DACRIDINE | 0 | 0 |
2008 | 2 | 28 | 1376 1967 CANADIAN JOURNAL OF MICROBIOLOGY 13 (1): 81-& PERRON JM; SMIRNOFF WA; HUOT L COMPARAISON DE TOXICITE DE QUELQUES ELEMENTS POUR BACILLUS THURINGIENSIS VAR THURINGIENSIS BERL | 0 | 1 |
2009 | 5 | 34 | 1572 1968 CANADIAN JOURNAL OF MICROBIOLOGY 14 (6): 667-& YAMAMOTO T; CHOW CT MITOMYCIN C INDUCTION OF A TEMPERATE PHAGE IN PSEUDOMONAS AERUGINOSA | 4 | 15 |
2010 | 1 | 27 | 1845 1969 CANADIAN JOURNAL OF MICROBIOLOGY 15 (4): 335-& BOVRE K; FIANDT M; SZYBALSKI W DNA BASE COMPOSITION OF NEISSERIA MORAXELLA AND ACINETOBACTER AS DETERMINED BY MEASUREMENT OF BUOYANT DENSITY IN CSCL GRADIENTS | 33 | 33 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
2011 | 1 | 4 | 1846 1969 CANADIAN JOURNAL OF MICROBIOLOGY 15 (5): 489-& HUNT DE; SANDHAM HJ EFFECT OF ETHYLENEDIAMINETETRAACETIC ACID ON ACTINOBOLIN-RESISTANCE IN ESCHERICHIA COLI | 1 | 3 |
2012 | 1 | 17 | 1847 1969 CANADIAN JOURNAL OF MICROBIOLOGY 15 (9): 1067-& AMIN AH; SUBBAIAH TV; ABBASI KM BERBERINE SULFATE - ANTIMICROBIAL ACTIVITY, BIOASSAY, AND MODE OF ACTION | 0 | 73 |
2013 | 1 | 34 | 2124 1970 CANADIAN JOURNAL OF MICROBIOLOGY 16 (9): 801-& COULTER WH; COSTILOW RN ROLE OF BARBITURIC ACID IN NUTRITION OF BACILLUS-POPILLIAE | 0 | 4 |
2014 | 1 | 17 | 2125 1970 CANADIAN JOURNAL OF MICROBIOLOGY 16 (10): 973-& BARABAS G; MEHTA BM; KUSHNER DJ PROFLAVINE BINDING AND RELEASE BY SENSITIVE AND RESISTANT BACILLUS-SUBTILIS | 0 | 3 |
2015 | 5 | 14 | 2468 1971 CANADIAN JOURNAL OF MICROBIOLOGY 17 (1): 87-& JONES RJ; HEWITT RR EFFECT OF 5-BROMOURACIL ON GROWTH OF A THYMINE AUXOTROPH OF ESCHERICHIA-COLI K-12 | 1 | 2 |
2016 | 1 | 28 | 2469 1971 CANADIAN JOURNAL OF MICROBIOLOGY 17 (12): 1491-& LAMBERT MA; THOMAS ML; WEAVER RE; MOSS CW; HOLLIS DG CELLULAR FATTY-ACIDS OF NONPATHOGENIC NEISSERIA | 2 | 28 |
2017 | 3 | 14 | 3186 1973 CANADIAN JOURNAL OF MICROBIOLOGY 19 (4): 531-533 LESLEY SM; BEHKI RM SENSITIVITY TO MYXIN OF ESCHERICHIA-COLI TREATED WITH ETHYLENEDIAMINETETRAACETIC ACID | 0 | 0 |
2018 | 7 | 17 | 3903 1975 CANADIAN JOURNAL OF MICROBIOLOGY 21 (7): 1116-1120 PAI CH; YAU HC CHROMOSOMAL LOCATION OF MUTATIONS AFFECTING REGULATION OF BIOTIN SYNTHESIS IN ESCHERICHIA-COLI | 4 | 10 |
2019 | 7 | 35 | 3904 1975 CANADIAN JOURNAL OF MICROBIOLOGY 21 (8): 1151-1159 FRANCIS MM; CELLA R; VINING IC GENETIC RECOMBINATION IN A CHLORAMPHENICOL-PRODUCING STRAIN OF STREPTOMYCES SPECIES 3022A | 2 | 11 |
2020 | 3 | 12 | 3905 1975 CANADIAN JOURNAL OF MICROBIOLOGY 21 (10): 1484-1491 MCCALLA DR; OLIVE P; TU Y; FAN ML NITROFURAZONE-REDUCING ENZYMES IN E-COLI AND THEIR ROLE IN DRUG ACTIVATION INVIVO | 5 | 54 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
2021 | 4 | 10 | 4266 1976 CANADIAN JOURNAL OF MICROBIOLOGY 22 (2): 301-303 CHOW CT RESISTANCE OF THIOBACILLUS-NOVELLUS TO MITOMYCIN-C AND RIFAMPICIN | 1 | 2 |
2022 | 1 | 30 | 4267 1976 CANADIAN JOURNAL OF MICROBIOLOGY 22 (9): 1222-1228 WARDLEY RC; BABIUK LA; ROUSE BT POLYMORPH-MEDIATED ANTIBODY-DEPENDENT CYTOTOXICITY-MODULATION OF ACTIVITY BY DRUGS AND IMMUNE INTERFERON | 0 | 23 |
2023 | 1 | 10 | 4268 1976 CANADIAN JOURNAL OF MICROBIOLOGY 22 (9): 1399-1401 JOBSON A; COOK FD; WESTLAKE DWS BUOYANT DENSITY, CONVERSION FORMULAS, AND MOLE PERCENT GUANOSINE + CYTOSINE CONTENT OF DESULFOVIBRIO SP | 0 | 0 |
2024 | 5 | 21 | 4618 1977 CANADIAN JOURNAL OF MICROBIOLOGY 23 (1): 45-51 WARNER FD; KITOS GA; ROMANO MP; HEMPHILL HE CHARACTERIZATION OF SPBETA - TEMPERATE BACTERIOPHAGE FROM BACILLUS-SUBTILIS-168M | 2 | 65 |
2025 | 3 | 22 | 4619 1977 CANADIAN JOURNAL OF MICROBIOLOGY 23 (4): 398-401 SAFE LM; SAFE SH; SUBDEN RE; MORRIS DC STEROL CONTENT AND POLYENE ANTIBIOTIC-RESISTANCE IN ISOLATES OF CANDIDA-KRUSEI, CANDIDA-PARAKRUSEI, AND CANDIDA-TROPICALIS | 1 | 49 |
2026 | 2 | 12 | 4620 1977 CANADIAN JOURNAL OF MICROBIOLOGY 23 (6): 751-754 SUBDEN RE; SAFE L; MORRIS DC; BROWN RG; SAFE S EBURICOL, LICHESTEROL, ERGOSTEROL, AND OBTUSIFOLIOL FROM POLYENE ANTIBIOTIC-RESISTANT MUTANTS OF CANDIDA-ALBICANS | 2 | 24 |
2027 | 2 | 31 | 4621 1977 CANADIAN JOURNAL OF MICROBIOLOGY 23 (9): 1123-1127 DEBETTE J; BLONDEAU R CHARACTERIZATION OF TELLURIC BACTERIA WITH CLOSE AFFINITY TO PSEUDOMONAS-MALTOPHILIA | 0 | 11 |
2028 | 3 | 52 | 4622 1977 CANADIAN JOURNAL OF MICROBIOLOGY 23 (10): 1415-1425 SKYRING GW; JONES HE; GOODCHILD D TAXONOMY OF SOME NEW ISOLATES OF DISSIMILATORY SULFATE-REDUCING BACTERIA | 0 | 26 |
2029 | 2 | 23 | 4623 1977 CANADIAN JOURNAL OF MICROBIOLOGY 23 (11): 1568-1572 TANENBAUM SW; FLASHNER M ARTHROBACTER-SIALOPHILUS SP-NOV - NEURAMINIDASE-PRODUCING CORYNEFORM | 0 | 9 |
2030 | 1 | 11 | 4960 1978 CANADIAN JOURNAL OF MICROBIOLOGY 24 (12): 1619-1621 VANTASSELL RL; WILKINS TD ISOLATION OF AUXOTROPHS OF BACTEROIDES-FRAGILIS | 2 | 31 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
2031 | 3 | 21 | 5267 1979 CANADIAN JOURNAL OF MICROBIOLOGY 25 (3): 291-297 RAPP BJ; KEMP JD; WHITE F ISOLATION OF A NON-TUMOR-INDUCING MUTANT OF THE TI PLASMID OF AGROBACTERIUM-TUMEFACIENS STRAIN-B6 | 0 | 1 |
2032 | 8 | 41 | 5268 1979 CANADIAN JOURNAL OF MICROBIOLOGY 25 (9): 1027-1035 COMPTON SW; MAYO JA; EHRLICH M; ACKERMANN HW; TREMBLAY L; et al. DNA-BASE COMPOSITION, NATURE OF INTRACELLULAR DNA, MORPHOLOGY, AND CLASSIFICATION OF BACTERIOPHAGES INFECTING MICROCOCCUS-LUTEUS | 1 | 4 |
2033 | 1 | 51 | 5611 1980 CANADIAN JOURNAL OF MICROBIOLOGY 26 (8): 881-886 MCCLUNG CR; PATRIQUIN DG ISOLATION OF A NITROGEN-FIXING CAMPYLOBACTER SPECIES FROM THE ROOTS OF SPARTINA-ALTERNIFLORA LOISEL | 0 | 36 |
2034 | 1 | 38 | 5612 1980 CANADIAN JOURNAL OF MICROBIOLOGY 26 (8): 938-951 MARTIN SM; ROGOLSKY M DNA-MEDIATED TRANSFORMATION IN MUTANTS OF PHAGE GROUP 2 STAPHYLOCOCCUS-AUREUS | 0 | 2 |
2035 | 4 | 35 | 5940 1981 CANADIAN JOURNAL OF MICROBIOLOGY 27 (2): 175-183 TAYLOR DE; LEVINE JG; SIBAY G; WALTER A GENETIC-STUDIES OF H-GROUP PLASMIDS BY BACTERIOPHAGE-P1 TRANSDUCTION | 0 | 1 |
2036 | 4 | 24 | 5941 1981 CANADIAN JOURNAL OF MICROBIOLOGY 27 (6): 616-626 KONARSKAKOZLOWSKA M; IYER VN THE GENETIC AND PHYSICAL BASIS OF VARIABILITY IN ESCHERICHIA-COLI STRAINS CARRYING A REFERENCE INC N-GROUP PLASMID | 0 | 14 |
2037 | 2 | 11 | 6291 1982 CANADIAN JOURNAL OF MICROBIOLOGY 28 (1): 141-144 DHILLON TS; DHILLON EKS; LINN S RESTRICTION FRAGMENT ANALYSIS FOR DIFFERENTIATION OF INDISTINGUISHABLE TEMPERATE COLIPHAGES | 0 | 2 |
2038 | 6 | 24 | 6292 1982 CANADIAN JOURNAL OF MICROBIOLOGY 28 (4): 406-413 BAHARAEEN S; BANTLE JA; VISHNIAC HS THE EVOLUTION OF ANTARCTIC YEASTS - DNA-BASE COMPOSITION AND DNA-DNA HOMOLOGY | 0 | 15 |
2039 | 1 | 22 | 6934 1984 CANADIAN JOURNAL OF MICROBIOLOGY 30 (5): 682-690 FEIN JE; TALLIM SR; LAWFORD GR EVALUATION OF D-XYLOSE FERMENTING YEASTS FOR UTILIZATION OF A WOOD-DERIVED HEMICELLULOSE HYDROLYSATE | 0 | 32 |
2040 | 6 | 25 | 7872 1988 CANADIAN JOURNAL OF MICROBIOLOGY 34 (12): 1288-1296 NATH SK ATTENUATION OF TRANSCRIPTION OF BIOTIN GENES IN ESCHERICHIA-COLI | 0 | 0 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
2041 | 7 | 22 | 9947 2003 CANADIAN JOURNAL OF MICROBIOLOGY 49 (3): 225-229 Slavcev RA; Bull HJ; Hayes S Bacteriophage lambda repressor allelic modulation of the Rex exclusion phenotype | 1 | 1 |
2042 | 22 | 60 | 10102 2005 CANADIAN JOURNAL OF MICROBIOLOGY 51 (1): 37-49 Hayes S; Slavcev R Polarity within p(M) and p(E) promoted phage lambda cl-rexA-rexB transcription and its suppression | 0 | 0 |
2043 | 9 | 16 | 3906 1975 CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE 10 (2): 271-276 WILSON FM; SMOLIN G; OKUMOTO M THERAPY OF EXPERIMENTAL HERPETIC KERATITIS WITH IDU AND FLUORESCENT LIGHT - NEGATIVE STUDY | 0 | 0 |
2044 | 1 | 33 | 8285 1990 CANADIAN JOURNAL OF SURGERY 33 (4): 265-270 WEBBER EM; MACFARLANE JK PREOPERATIVE RADIOTHERAPY FOR ADENOCARCINOMA OF THE RECTUM | 0 | 1 |
2045 | 3 | 136 | 1175 1966 CANADIAN MEDICAL ASSOCIATION JOURNAL 94 (1): 23-& LARKE RPB INTERFERON - A CHANGING PICTURE | 0 | 12 |
2046 | 4 | 16 | 619 1963 CANCER 16 (3): 355-& FLETCHER GH; SUIT HD; HOWE CD; SAMUELS M; VILLAREAL RU; et al. CLINICAL METHOD OF TESTING RADIATION-SENSITIZING AGENTS IN SQUAMOUS CELL CARCINOMA | 7 | 47 |
2047 | 2 | 36 | 1176 1966 CANCER 19 (1): 103-& BICKIS IJ; HENDERSO.IW; QUASTEL JH BIOCHEMICAL STUDIES OF HUMAN TUMORS .2. IN VITRO ESTIMATION OF INDIVIDUAL TUMOR SENSITIVITY TO ANTICANCER AGENTS | 1 | 69 |
2048 | 5 | 27 | 1377 1967 CANCER 20 (1): 31-& NASJLETI CE; SPENCER HH CHROMOSOME POLYPLOIDIZATION IN HUMAN LEUKOCYTE CULTURES TREATED WITH STREPTONIGRIN AND CYCLOPHOSPHAMIDE | 1 | 33 |
2049 | 3 | 34 | 1378 1967 CANCER 20 (3): 333-& TAN C; TASAKA H; YU KP; MURPHY ML; KARNOFSK.DA DAUNOMYCIN AN ANTITUMOR ANTIBIOTIC IN TREATMENTT OF NEOPLASTIC DISEASE - CLINICAL EVALUATION WITH SPECIAL REFERENCE TO CHILDHOOD LEUKEMIA | 21 | 276 |
2050 | 19 | 198 | 1573 1968 CANCER 21 (1): 58-& VERMUND H; GOLLIN FF MECHANISMS OF ACTION OF RADIOTHERAPY AND CHEMOTHERAPEUTIC ADJUVANTS - A REVIEW | 7 | 50 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
2051 | 1 | 87 | 2126 1970 CANCER 26 (4): 737-& HADDOW A THOUGHTS ON CHEMICAL THERAPY | 0 | 6 |
2052 | 2 | 15 | 2804 1972 CANCER 29 (5): 1293-& SUTOW WW; TALLEY RW; VIETTI TJ; LONSDALE D DAUNOMYCIN IN TREATMENT OF METASTATIC SOFT-TISSUE SARCOMA IN CHILDREN | 0 | 7 |
2053 | 3 | 80 | 3907 1975 CANCER 35 (1): 111-120 BLOOM HJG COMBINED MODALITY THERAPY FOR INTRACRANIAL TUMORS | 1 | 105 |
2054 | 1 | 20 | 4269 1976 CANCER 37 (2): 1218-1225 HALL TC LATE EFFECTS OF CANCER-THERAPY - ROLE OF CLINICAL PHARMACOLOGIST | 0 | 1 |
2055 | 7 | 64 | 4624 1977 CANCER 39 (2): 987-999 PHILLIPS TL CHEMICAL MODIFICATION OF RADIATION EFFECTS | 2 | 40 |
2056 | 3 | 29 | 4961 1978 CANCER 41 (2): 403-414 MIYAMOTO T; TAKABE Y; WATANABE M; TERASIMA T EFFECTIVENESS OF A SEQUENTIAL COMBINATION OF BLEOMYCIN AND MITOMYCIN-C ON AN ADVANCED CERVICAL-CANCER | 3 | 75 |
2057 | 17 | 221 | 5942 1981 CANCER 47 (10): 2327-2345 MILLER EC; MILLER JA SEARCHES FOR ULTIMATE CHEMICAL CARCINOGENS AND THEIR REACTIONS WITH CELLULAR MACROMOLECULES | 6 | 646 |
2058 | 2 | 19 | 6293 1982 CANCER 49 (10): 1953-1957 MILSTEIN C MONOCLONAL-ANTIBODIES | 0 | 13 |
2059 | 3 | 23 | 6596 1983 CANCER 51 (4): 600-605 MABEL JA; WODINSKY I MITOMYCIN-C COMBINATION THERAPY AGAINST MURINE TUMOR SYSTEMS - EFFECTIVENESS WITH CYCLOPHOSPHAMIDE AND METHOTREXATE | 0 | 1 |
2060 | 4 | 52 | 6935 1984 CANCER 53 (10): 2034-2040 AMES BN THE DETECTION OF ENVIRONMENTAL MUTAGENS AND POTENTIAL CARCINOGENS | 0 | 12 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
2061 | 9 | 139 | 7213 1985 CANCER 55 (9): 2037-2050 BRADY LW; MARKOE AM; SHELINE GE; SUNTHARALINGAM N; SUTHERLAND RM RADIATION ONCOLOGY - PROGRAMS FOR THE PRESENT AND FUTURE | 0 | 5 |
2062 | 8 | 81 | 7214 1985 CANCER 56 (10): 2351-2363 ELKIND MM DNA DAMAGE AND CELL KILLING - CAUSE AND EFFECT | 0 | 48 |
2063 | 10 | 29 | 7675 1987 CANCER 59 (5): 908-915 KINSELLA TJ; GLATSTEIN E CLINICAL-EXPERIENCE WITH INTRAVENOUS RADIOSENSITIZERS IN UNRESECTABLE SARCOMAS | 18 | 40 |
2064 | 3 | 28 | 7873 1988 CANCER 61 (9): 1741-1748 YOSHIDA H; OISHI Y; YANAGAWA T; YURA Y; AZUMA M; et al. ENHANCEMENT OF CIS-DIAMMINEDICHLOROPLATINUM AND MITOMYCIN-C-INDUCED SISTER CHROMATID EXCHANGES BY DIBUTYRYL CYCLIC-AMP IN A HUMAN SALIVARY-GLAND ADENOCARCINOMA CELL-LINE IN CULTURE | 0 | 5 |
2065 | 10 | 36 | 7874 1988 CANCER 61 (12): 2433-2438 NAGASHIMA T; HOSHINO T; CHO KG; EDWARDS MSB; HUDGINS RJ; et al. THE PROLIFERATIVE POTENTIAL OF HUMAN EPENDYMOMAS MEASURED BY INSITU BROMODEOXYURIDINE LABELING | 0 | 37 |
2066 | 6 | 31 | 7875 1988 CANCER 62 (4): 740-748 CHO KG; DEARMOND SJ; BARNWELL S; EDWARDS MSB; HOSHINO T PROLIFERATIVE CHARACTERISTICS OF INTRACRANIAL AND SPINAL TUMORS OF DEVELOPMENTAL ORIGIN | 1 | 7 |
2067 | 7 | 28 | 8286 1990 CANCER 66 (1): 30-34 KERSH CR; CONSTABLE WC; SPAULDING CA; HAHN SS; ANDERSEN WA; et al. A PHASE-I-II TRIAL OF MULTIMODALITY MANAGEMENT OF BULKY GYNECOLOGIC MALIGNANCY - COMBINED CHEMORADIOSENSITIZATION AND RADIOTHERAPY | 0 | 20 |
2068 | 1 | 26 | 9334 1996 CANCER 78 (4): 827-833 Chowdhury GM; Kojima K; Kanayama H; Tsuji M; Kurokawa Y; et al. The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract | 0 | 10 |
2069 | 1 | 49 | 9477 1997 CANCER 80 (8): 1472-1481 Popov Z; Hoznek A; Colombel M; BastujiGarin S; LefrereBelda MA; et al. The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder | 0 | 58 |
2070 | 28 | 75 | 8842 1993 CANCER AND METASTASIS REVIEWS 12 (2): 83-101 ROSS D; SIEGEL D; BEALL H; PRAKASH AS; MULCAHY RT; et al. DT-DIAPHORASE IN ACTIVATION AND DETOXIFICATION OF QUINONES - BIOREDUCTIVE ACTIVATION OF MITOMYCIN-C | 12 | 122 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
2071 | 35 | 62 | 8843 1993 CANCER AND METASTASIS REVIEWS 12 (2): 165-176 ROCKWELL S; SARTORELLI AC; TOMASZ M; KENNEDY KA CELLULAR PHARMACOLOGY OF QUINONE BIOREDUCTIVE ALKYLATING-AGENTS | 3 | 40 |
2072 | 9 | 29 | 5269 1979 CANCER BIOCHEMISTRY BIOPHYSICS 3 (3): 129-134 BIAGINI RE; PARDINI RS; LIN AJ; SARTORELLI AC EFFECTS OF THE BIOREDUCTIVE ALKYLATING AGENT 2,3-BIS(CHLOROMETHYL)-1,4-NAPHTHOQUINONE ON COUPLED MITOCHONDRIA ISOLATED FROM SARCOMA 180 ASCITES-CELLS | 3 | 6 |
2073 | 2 | 17 | 8085 1989 CANCER BIOCHEMISTRY BIOPHYSICS 10 (4): 337-343 SCHOENBERGER OL; BEIKIRCH S CELL-CYCLE PHASES OF 2 HUMAN-LUNG TUMOR-CELL LINES DERIVED FROM SQUAMOUS-CELL CARCINOMA AND PULMONARY METASTASIS OF A RHABDOMYOSARCOMA (HS-24 AND HS-57) AND NORMAL-ACETYLALANINE AMINOPEPTIDASE ACTIVITY | 0 | 0 |
2074 | 11 | 50 | 8287 1990 CANCER BIOCHEMISTRY BIOPHYSICS 11 (4): 275-287 MUKHERJEE U; BASAK J; CHATTERJEE SN DNA DAMAGE AND CELL KILLING BY NITROFURANTOIN IN RELATION TO ITS CARCINOGENIC POTENTIAL | 2 | 8 |
2075 | 1 | 44 | 8288 1990 CANCER CELLS-A MONTHLY REVIEW 2 (3): 79-83 SKANDALIS A; GLICKMAN BW ENDOGENOUS GENE SYSTEMS FOR THE STUDY OF MUTATIONAL SPECIFICITY IN MAMMALIAN-CELLS | 0 | 13 |
2076 | 2 | 90 | 4962 1978 CANCER CHEMOTHERAPY AND PHARMACOLOGY 1 (2): 83-90 DAVIS HL; HOFF DDV; HENNEY JE; ROZENCWEIG M ROLE OF ANTI-TUMOR ANTIBIOTICS IN CURRENT ONCOLOGIC PRACTICE | 1 | 14 |
2077 | 4 | 18 | 4963 1978 CANCER CHEMOTHERAPY AND PHARMACOLOGY 1 (4): 243-247 CONTRERAS A; SANCHEZPEREZ RM; ALONSO G HALOMETHYL-1,2,3-TRIAZOLE DERIVATIVES - NEW TYPE OF ALKYLATING AGENT ACTIVE IN MOUSE TRANSPLANTABLE TUMORS | 0 | 14 |
2078 | 30 | 248 | 5270 1979 CANCER CHEMOTHERAPY AND PHARMACOLOGY 3 (3): 143-160 VIG BK MUTAGENIC EFFECTS OF SOME ANTI-CANCER ANTIBIOTICS | 0 | 19 |
2079 | 2 | 117 | 5943 1981 CANCER CHEMOTHERAPY AND PHARMACOLOGY 6 (1): 1-9 POWIS G; AMES MM; KOVACH JS DOSE-DEPENDENT PHARMACOKINETICS AND CANCER-CHEMOTHERAPY | 0 | 27 |
2080 | 12 | 41 | 7876 1988 CANCER CHEMOTHERAPY AND PHARMACOLOGY 22 (2): 126-130 SCHLAGER JJ; POWIS G MITOMYCIN-C IS NOT METABOLIZED BY BUT IS AN INHIBITOR OF HUMAN-KIDNEY NAD(P)H-(QUINONE-ACCEPTOR)OXIDOREDUCTASE | 19 | 49 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
2081 | 7 | 43 | 8086 1989 CANCER CHEMOTHERAPY AND PHARMACOLOGY 23: S68-S73 ENSMINGER W HEPATIC ARTERIAL CHEMOTHERAPY FOR PRIMARY AND METASTATIC LIVER CANCERS | 0 | 12 |
2082 | 15 | 28 | 8087 1989 CANCER CHEMOTHERAPY AND PHARMACOLOGY 25 (1): 45-50 MAYBAUM J; HAFNER MS; BURTON EC; STETSON PL; ENSMINGER WD; et al. RESPONSE OF HUMAN HT-29 COLORECTAL TUMOR-CELLS TO EXTENDED EXPOSURE TO BROMODEOXYURIDINE | 1 | 4 |
2083 | 17 | 34 | 8289 1990 CANCER CHEMOTHERAPY AND PHARMACOLOGY 27 (3): 187-193 PAN SS PORFIROMYCIN DISPOSITION IN OXYGEN-MODULATED P388 CELLS | 13 | 19 |
2084 | 5 | 17 | 8479 1991 CANCER CHEMOTHERAPY AND PHARMACOLOGY 28 (3): 228-230 GUSTAFSON DL; PRITSOS CA INHIBITION OF MITOMYCIN-C AEROBIC TOXICITY BY THE SELENOORGANIC ANTIOXIDANT PZ-51 | 1 | 7 |
2085 | 8 | 40 | 8658 1992 CANCER CHEMOTHERAPY AND PHARMACOLOGY 29 (4): 290-296 GHIORGHIS A; TALEBIAN A; CLARKE R INVITRO ANTINEOPLASTIC ACTIVITY OF C7-SUBSTITUTED MITOMYCIN-C ANALOGS MC-77 AND MC-62 AGAINST HUMAN BREAST-CANCER CELL-LINES | 0 | 1 |
2086 | 1 | 27 | 9020 1994 CANCER CHEMOTHERAPY AND PHARMACOLOGY 33 (4): 291-297 MATSUNAGA H; KATANO M; SAITA T; YAMAMOTO H; MORI M POTENTIATION OF CYTOTOXICITY OF MITOMYCIN-C BY A POLYACETYLENIC ALCOHOL, PANAXYTRIOL | 0 | 21 |
2087 | 13 | 22 | 9169 1995 CANCER CHEMOTHERAPY AND PHARMACOLOGY 35 (4): 318-322 CHIRREY L; CUMMINGS J; HALBERT GW; SMYTH JF CONVERSION OF MITOMYCIN-C TO 2,7-DIAMINOMITOSENE AND 10-DECARBAMOYL 2,7-DIAMINOMITOSENE IN TUMOR-TISSUE IN-VIVO | 9 | 17 |
2088 | 5 | 27 | 9478 1997 CANCER CHEMOTHERAPY AND PHARMACOLOGY 40 (6): 463-468 Chelladurai M; Lobocki CA; Sultani M; Hanna Y; Drelichman A; et al. Bromodeoxyuridine improves the cytotoxic effect of cisplatin: a comparison with 5-fluorouracil | 1 | 4 |
2089 | 3 | 51 | 9948 2003 CANCER CHEMOTHERAPY AND PHARMACOLOGY 52 (4): 325-332 Ostruszka LJ; Shewach DS The role of DNA synthesis inhibition in the cytotoxicity of 2 ',2 '- difluoro-2 '-deoxycytidine | 0 | 3 |
2090 | 0 | 40 | 292 1960 CANCER CHEMOTHERAPY REPORTS (6): 29-36 WELCH AD; PRUSOFF WH A SYNOPSIS OF RECENT INVESTIGATIONS OF 5-IODO-2'-DEOXYURIDINE | 3 | 10 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
2091 | 1 | 72 | 293 1960 CANCER CHEMOTHERAPY REPORTS (6): 94-114 [Anon] 5-FLUOROURACIL AND ITS RIBOSIDES | 0 | 0 |
2092 | 1 | 122 | 294 1960 CANCER CHEMOTHERAPY REPORTS (7): 65-86 DUVALL LR AZASERINE | 1 | 1 |
2093 | 1 | 58 | 295 1960 CANCER CHEMOTHERAPY REPORTS (7): 86-98 DUVALL LR 6-DIAZO-5-OXO-L-NORLEUCINE | 1 | 2 |
2094 | 1 | 36 | 296 1960 CANCER CHEMOTHERAPY REPORTS (8): 156-175 DUVALL LR TRIS(1-AZIRIDINYL)PHOSPHINE OXIDE (TEPA) | 0 | 1 |
2095 | 8 | 22 | 362 1961 CANCER CHEMOTHERAPY REPORTS (11): 51-56 GREENBERG J; MANDELL JD; WOODY PL A PRELIMINARY REPORT - RESISTANCE AND CROSS-RESISTANCE OF ESCHERICHIA-COLI MUTANTS TO RADIOMIMETIC AGENTS | 0 | 1 |
2096 | 7 | 18 | 363 1961 CANCER CHEMOTHERAPY REPORTS (11): 87-89 SZYBALSKI W; SZYBALSKA EH A NEW CHEMOTHERAPEUTIC PRINCIPLE FOR THE TREATMENT OF DRUG-RESISTANT NEOPLASMS | 0 | 0 |
2097 | 1 | 154 | 364 1961 CANCER CHEMOTHERAPY REPORTS (11): 177-237 [Anon] DATA SUMMARIES OF SELECTED PURINE ANTAGONISTS | 0 | 0 |
2098 | 1 | 16 | 365 1961 CANCER CHEMOTHERAPY REPORTS (14): 174-179 DUVALL LR ROSS AZO MUSTARD | 0 | 0 |
2099 | 1 | 6 | 2127 1970 CANCER CHEMOTHERAPY REPORTS PART 1 54 (3): 195-& WHITTING.RM; CLOSE HP CLINICAL EXPERIENCE WITH MITOMYCIN C (NSC-26980) | 0 | 57 |
2100 | 2 | 8 | 2128 1970 CANCER CHEMOTHERAPY REPORTS PART 1 54 (4): 283-& SUTOW WW; FERNBACH DJ; THURMAN WG; HOLTON CP; WATKINS WL DAUNOMYCIN (NSC-82151) IN TREATMENT OF METASTATIC NEUROBLASTOMA | 0 | 9 |
Page 21 of 102: 1 11 [ 21 22 23 24 25 26 27 28 29 30 ] 31 41 51 61 71 81 91 | 101
Generated by:
HistCite 2005.08.29